Active Ingredient History

  • Now
Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. Gemcitabine inhibits thymidylate synthetase, leading to inhibition of DNA synthesis and cell death. Gemcitabine is a prodrug so activity occurs as a result of intracellular conversion to two active metabolites, gemcitabine diphosphate and gemcitabine triphosphate by deoxycitidine kinase. Gemcitabine diphosphate also inhibits ribonucleotide reductase, the enzyme responsible for catalyzing synthesis of deoxynucleoside triphosphates required for DNA synthesis. Finally, Gemcitabine triphosphate (diflurorodeoxycytidine triphosphate) competes with endogenous deoxynucleoside triphosphates for incorporation into DNA. Gemcitabine is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy; metastatic ovarian cancer; inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer; and locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas.   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$0.5449 - $744.6700


$18.8475 - $30.0351
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2',2'-dfdc | 2',2'-difluoro-2'-deoxycytidine | 2',2'-difluorodeoxycytidine | 2'-deoxy-2',2'-difluorocytidine | 2'-deoxy-2',2''-difluorocytidine-5'-o-monophosphate | 2'-deoxy-2'-difluorocytidine | 4-amino-1-((2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1h)-one | ca-101 | co-101 | co-1.01 | cp4126 | cp 4126 | cp-4126 | dfdcyd | gamcitabine | gemcitabin | gemcitabina | gemcitabine | gemcitabine, (alpha-d-threo-pentofuranosyl)-isomer | gemcitabine, (beta-d-threo-pentafuranosyl)-isomer | gemcitabine, (d-threo-pentafuranosyl)-isomer | gemcitabine elaidate | gemcitabine hcl | gemcitabine hydrochloride | gemcitabine - nabpaclitaxel | gemcitabinum | gemcitibine | gemox | gemzar | ly 188011 | ly-188011 | oxaliplatin | urlc10 peptide


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue